Diana Do, MD
Stanford Byers Eye Institute · University of Nebraska · Truhlsen Eye Institute, University of Nebraska Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Diana Do, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:06 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06172257 · A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)Oculis · completed · Diabetic Macular Edema · principal investigator
- Ph2NCT02511067 · Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 StudyUniversity of Nebraska · withdrawn · Diabetic Macular Edema · principal investigator
- Ph2NCT00407381 · The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) StudyJohns Hopkins University · completed · Diabetic Macular Edema · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:06 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.